Form 8-K - Current report:
SEC Accession No. 0001641172-25-006043
Filing Date
2025-04-24
Accepted
2025-04-24 17:28:31
Documents
17
Period of Report
2025-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49396
2 ex4-1.htm EX-4.1 138841
3 ex10-1.htm EX-10.1 184149
4 ex99-1.htm EX-99.1 13323
5 ex99-1_001.jpg GRAPHIC 6739
  Complete submission text file 0001641172-25-006043.txt   642271

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aztr-20250424.xsd EX-101.SCH 3018
7 XBRL LABEL FILE aztr-20250424_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE aztr-20250424_pre.xml EX-101.PRE 22361
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3668
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 25869009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)